Canadian Headache Society guideline for migraine prophylaxis.

scientific article

Canadian Headache Society guideline for migraine prophylaxis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID22683887

P50authorLawrence RicherQ44810103
P2093author name stringWerner J Becker
Tamara Pringsheim
Gordon Mackie
Suzanne N Christie
Michel Aubé
Jonathan Gladstone
Irene Worthington
Canadian Headache Society Prophylactic Guidelines Development Group
W Jeptha Davenport
P433issue2 Suppl 2
P921main subjectheadacheQ86
migraineQ133823
P304page(s)S1-59
P577publication date2012-03-01
P1433published inCanadian Journal of Neurological SciencesQ5030246
P1476titleCanadian Headache Society guideline for migraine prophylaxis
P478volume39

Reverse relations

cites work (P2860)
Q38050981A possible role for mitochondrial dysfunction in migraine
Q87386123ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They?
Q57492131Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats
Q47613993Amitriptyline and Sexual Function: A Systematic Review Updated for Sexual Health Practice
Q89447972Auricular acupuncture for migraine: A systematic review protocol
Q64253546CGRP monoclonal antibody for preventive treatment of chronic migraine: An update of meta-analysis
Q38254097Current and investigational drugs for the prevention of migraine in adults and children
Q36387731Dietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine
Q90084512Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults
Q93197713Factors Affecting Preventive Treatment Outcomes for Patients With Newly Diagnosed Chronic Migraine and Their Compliance With Treatment Recommendations in Chongqing Province, China: An Open-Label Prospective Study With Retrospective Baseline
Q38658278Factors Associated with Favorable Outcome of Topiramate Migraine Prophylaxis in Pediatric Patients.
Q92535802Flunarizine Induced Parkinsonism in Migraine Group: A Nationwide Population-Based Study
Q24201830Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults
Q34303798How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).
Q28647495Interventions for migraine prophylaxis: protocol of an umbrella systematic review and network meta-analysis
Q36832984Magnesium in disease prevention and overall health
Q36927873Management of headache and associated factors among undergraduate medicine and health science students of University of Gondar, North West Ethiopia
Q38784408Managing Migraine During Pregnancy and Lactation
Q90659710Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial
Q30245474Medication-overuse headache: risk factors, pathophysiology and management
Q92874875Mutual Enhancement of Opioid and Adrenergic Receptors by Combinations of Opioids and Adrenergic Ligands Is Reflected in Molecular Complementarity of Ligands: Drug Development Possibilities
Q37410902New advances in prevention of migraine. Review of current practice and recent advances
Q35938798Nutraceuticals in Acute and Prophylactic Treatment of Migraine
Q89685739Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study
Q39239760Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine
Q43063871Pharmacological treatment of migraine during pregnancy and breastfeeding
Q36267944Preventive Migraine Treatment
Q36873484Preventive treatment in migraine and the new US guidelines
Q26743537Recent advances in migraine therapy
Q90730011Refining the Benefit/Risk Profile of Anti-Epileptic Drugs in Headache Disorders
Q48761835Riboflavin and migraine: the bridge over troubled mitochondria
Q48969987Riboflavin in cyclic vomiting syndrome: efficacy in three children
Q24186656Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
Q34658774Studies on the pathophysiology and genetic basis of migraine.
Q88271261The Evidence for the Role of Nutraceuticals in the Management of Pediatric Migraine: a Review
Q43131557The Importance of Magnesium in Clinical Healthcare.
Q91589079The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis
Q58605238The management of common recurrent headaches by chiropractors: a descriptive analysis of a nationally representative survey
Q43242978The subtle central effect of nutraceuticals: Is it placebo or nocebo?
Q47136993The treatment of migraine patients within chiropractic: analysis of a nationally representative survey of 1869 chiropractors.
Q40994128Topiramate for pediatric migraine prevention
Q92626644Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists
Q97520894Update of Individualized Treatment Strategies for Postural Orthostatic Tachycardia Syndrome in Children
Q39394084Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women
Q38585393What Constitutes an "Adequate" Trial in Migraine Prevention?
Q47102957Le topiramate en prévention de la migraine chez les enfants

Search more.